TransCode Therapeutics(RNAZ)
$1.16-0.14 (-10.77%)
RNAZ
TransCode Therapeutics earnings date
$1.16
At close:-0.14 (-10.77%)
Want to see RNAZ full AI Analyst Report?
TransCode Therapeutics (RNAZ) Q2 2021 Earnings Report
447 Followers
RNAZ Q2 2021 EPS Results
- Actual EPS
- $158,721.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$7,288.51
RNAZ Q2 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/23/2021
- Time
- After Close
- Conference Call
- Monday, August 23, 2021
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
RNAZ Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 28, 2025 | 2024 (Q4) | -105.93-8.50 | -805.2 | 98.94% (+796.70) | |
| Nov 11, 2024 | 2024 (Q3) | -16.17-5.28 | -2217.6 | 99.76% (+2212.32) | |
| Aug 12, 2024 | 2024 (Q2) | -0.58-0.74 | -131.6 | 99.44% (+130.86) | |
| May 13, 2024 | 2024 (Q1) | ―- | -0.33 | ― | |
| Apr 03, 2024 | 2023 (Q4) | -646.80-600.60 | -12196.8 | 95.08% (+11596.20) | |
| Nov 14, 2023 | 2023 (Q3) | -55440.00-62092.80 | -243936 | 74.55% (+181843.20) | |
| Aug 14, 2023 | 2023 (Q2) | -121598.40-121598.40 | -266112 | 54.31% (+144513.60) | |
| May 15, 2023 | 2023 (Q1) | ―- | -0.27 | ― | |
| Mar 31, 2023 | 2022 (Q4) | ―-12196.80 | -199584 | 93.89% (+187387.20) | |
| Nov 14, 2022 | 2022 (Q3) | -243936.00-243936.00 | -147840 | -65.00% (-96096.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

